CompaniesByCap
AIXC
Qualigen Therapeutics Inc. (AIXC)
NASDAQ · Healthcare

Qualigen Therapeutics Inc. Cash Flow 2020–2022

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Mar 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-7.0M-6.3M-10.3M-13.2M-14.7M57,331-14.5M-13.3M-7.4M-15.2M
Depreciation & Amort.4,49512,165113,218216,6026,0935,721
Investing Activities
Capital Expenditure164,684134,4716,9741,5892,0087,6788,063
Free Cash Flow-13.4M-14.9M50,357-14.5M-13.3M-7.4M-15.2M
Financing Activities
Dividends Paid
Stock Buybacks

Qualigen Therapeutics Inc. Cash Flow — FAQ

Qualigen Therapeutics Inc. (AIXC) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AIXC's cash flow history?

The chart and table above show Qualigen Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.